Sanofi (France Medicine unit) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Sanofi (France Medicine unit) General Information

Description

Provider of pharmaceuticals. The business unit produces the following pharamceutical products: Surgestone, Provames, Speciafoldine and Tredemine. Surgestone and Provames are used for women's health indications; Speciafoldine is used to treat macrocytic anemia; and Tredemine is a World Health Organization recognized essential medicine to treat tapeworm.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Merus Labs International
Primary Office
  • France
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sanofi (France Medicine unit) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sanofi (France Medicine unit)‘s full profile, request access.

Request a free trial

Sanofi (France Medicine unit) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Sanofi (France Medicine unit)‘s full profile, request access.

Request a free trial